Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

FORM 8.3 - WILLIS TOWERS WATSON PLC

4th May 2021 13:22

 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)

Barclays PLC.

Company dealt in

WILLIS TOWERS WATSON PLC

Class of relevant security to which the

ORD

dealings being disclosed relate (Note 2)
Date of dealing

03 May 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:ORD

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

1,700,061

1.32%

165,980

0.13%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

72,359

0.06%

0

0.00%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

6,100

0.00%

6,100

0.00%

 

 

 

 

TOTAL:

 

 

 

 

1,778,520

1.38%

172,080

0.13%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit

Purchase

1

261.1000 USD

Purchase

1

259.5500 USD

Purchase

2

261.3050 USD

Purchase

3

261.2600 USD

Purchase

12

258.7300 USD

Purchase

20

261.7300 USD

Purchase

37

261.1664 USD

Purchase

57

261.5798 USD

Purchase

62

259.0800 USD

Purchase

80

261.8900 USD

Purchase

100

261.8000 USD

Purchase

100

261.6000 USD

Purchase

100

261.5600 USD

Purchase

111

261.5026 USD

Purchase

115

259.5004 USD

Purchase

127

259.3100 USD

Purchase

200

261.2390 USD

Purchase

214

261.5519 USD

Purchase

556

261.1139 USD

Purchase

603

260.9728 USD

Purchase

750

259.5857 USD

Purchase

820

259.2536 USD

Purchase

1,757

260.0329 USD

Purchase

2,025

260.9885 USD

Purchase

2,392

260.8907 USD

Purchase

2,954

260.3891 USD

Purchase

3,563

259.8644 USD

Purchase

4,100

260.9839 USD

Purchase

4,124

260.9900 USD

Purchase

12,007

260.7429 USD

Purchase

18,568

260.9263 USD

Purchase

34,750

261.2522 USD

Sale

1

260.7200 USD

Sale

1

261.1900 USD

Sale

1

261.8700 USD

Sale

15

261.2000 USD

Sale

100

261.3600 USD

Sale

100

260.9300 USD

Sale

100

261.2200 USD

Sale

100

261.3700 USD

Sale

127

259.3100 USD

Sale

134

261.3649 USD

Sale

150

261.9800 USD

Sale

150

261.4266 USD

Sale

159

260.9671 USD

Sale

200

260.9250 USD

Sale

200

261.0250 USD

Sale

226

261.9640 USD

Sale

300

261.1400 USD

Sale

400

261.2390 USD

Sale

495

261.2708 USD

Sale

500

261.2060 USD

Sale

506

260.6266 USD

Sale

600

261.0291 USD

Sale

726

260.9844 USD

Sale

800

261.0012 USD

Sale

959

261.3550 USD

Sale

1,100

261.0200 USD

Sale

1,112

261.5132 USD

Sale

1,187

261.0838 USD

Sale

1,201

259.8305 USD

Sale

1,247

260.8309 USD

Sale

1,365

261.4413 USD

Sale

1,690

261.1204 USD

Sale

2,065

260.9920 USD

Sale

2,469

260.5199 USD

Sale

2,525

261.3785 USD

Sale

2,752

261.2609 USD

Sale

2,800

260.9403 USD

Sale

3,258

260.9900 USD

Sale

4,191

259.1972 USD

Sale

5,555

260.7813 USD

Sale

7,369

260.7674 USD

Sale

17,567

260.8749 USD

Sale

23,808

261.2296 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?

YES

Date of disclosure:

4 May 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection

 

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name

Written or

Number of

Exercise

Type

Expiry

purchased

relevant securities

price

 

date

 

to which the option

 

 

 

 

or derivative

 

 

 

 

relates

 

 

 

Put Options

Purchased

-100

220.0000

American

Jul 16, 2021

Call Options

Purchased

100

240.0000

American

Jul 16, 2021

Call Options

Purchased

6,000

220.0000

American

Jul 16, 2021

Put Options

Purchased

-6,000

200.0000

American

Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210504005790/en/

Copyright Business Wire 2021


Related Shares:

Barclays
FTSE 100 Latest
Value8,837.91
Change26.87